114 related articles for article (PubMed ID: 8823254)
1. The influence of lymphangiography on the development of hypothyroidism in patients irradiated for Hodgkin's disease.
Fein DA; Hanlon AL; Corn BW; Curran WJ; Coia LR
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):13-8. PubMed ID: 8823254
[TBL] [Abstract][Full Text] [Related]
2. Thyroid function after mantle irradiation in Hodgkin's disease.
Smith RE; Adler RA; Clark P; Brinck-Johnsen T; Tulloh ME; Colton T
JAMA; 1981 Jan; 245(1):46-9. PubMed ID: 6253696
[TBL] [Abstract][Full Text] [Related]
3. Thyroid diseases after treatment of Hodgkin's disease.
Hancock SL; Cox RS; McDougall IR
N Engl J Med; 1991 Aug; 325(9):599-605. PubMed ID: 1861693
[TBL] [Abstract][Full Text] [Related]
4. Thyroid Abnormalities after Therapy for Hodgkin's Disease in Childhood.
Bhatia S; Ramsay NK; Bantle JP; Mertens A; Robison LL
Oncologist; 1996; 1(1 & 2):62-67. PubMed ID: 10387970
[TBL] [Abstract][Full Text] [Related]
5. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
Liao Z; Ha CS; Vlachaki MT; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox JD
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):971-7. PubMed ID: 11429225
[TBL] [Abstract][Full Text] [Related]
6. Thyroid function in pediatric patients after neck irradiation for Hodgkin disease.
Green DM; Brecher ML; Yakar D; Blumenson LE; Lindsay AN; Voorhess ML; MacGillivray M; Freeman AI
Med Pediatr Oncol; 1980; 8(2):127-36. PubMed ID: 7421731
[TBL] [Abstract][Full Text] [Related]
7. Thyroid toxicity of treatment for Hodgkin's disease.
Bethge W; Guggenberger D; Bamberg M; Kanz L; Bokemeyer C
Ann Hematol; 2000 Mar; 79(3):114-8. PubMed ID: 10803932
[TBL] [Abstract][Full Text] [Related]
8. Pelvic relapse following subtotal lymphoid irradiation in early stage Hodgkin's disease--an analysis of risk, management, and outcome.
Tate DJ; Hoppe RT
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1239-44. PubMed ID: 7607947
[TBL] [Abstract][Full Text] [Related]
9. Thyroid dysfunction following external irradiation to the neck for Hodgkin's disease in childhood.
Shalet SM; Rosenstock JD; Beardwell CG; Pearson D; Jones PH
Clin Radiol; 1977 Sep; 28(5):511-5. PubMed ID: 589902
[TBL] [Abstract][Full Text] [Related]
10. Thyroid dysfunction after mantle irradiation of Hodgkin's disease patients.
Khoo VS; Liew KH; Crennan EC; D'Costa IM; Quong G
Australas Radiol; 1998 Feb; 42(1):52-7. PubMed ID: 9509606
[TBL] [Abstract][Full Text] [Related]
11. Lymphangiography. Its practical value in surgically staged patients with Hodgkin's disease.
Kadin MR; Thompson RW
West J Med; 1974 Mar; 120(3):193-9. PubMed ID: 4816398
[TBL] [Abstract][Full Text] [Related]
12. Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin's lymphoma.
Cella L; Conson M; Caterino M; De Rosa N; Liuzzi R; Picardi M; Grimaldi F; Solla R; Farella A; Salvatore M; Pacelli R
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1802-8. PubMed ID: 21514076
[TBL] [Abstract][Full Text] [Related]
13. Prevention of hypothyroidism related to mantle irradiation for Hodgkin's disease: preparative phantom study.
Marcial-Vega VA; Order SE; Lastner G; Cole PD; LaFrance N; O'Neill M
Int J Radiat Oncol Biol Phys; 1990 Mar; 18(3):613-8. PubMed ID: 2318694
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of treatment for Ann Arbor Stage I Hodgkin's disease: prognostic factors for survival and freedom from progression.
Vlachaki MT; Hagemeister FB; Fuller LM; Besa PC; Hess MA; Brown B; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):593-9. PubMed ID: 9231684
[TBL] [Abstract][Full Text] [Related]
15. Thyroid function 10-18 years after mantle field irradiation for Hodgkin's disease.
Peerboom PF; Hassink EA; Melkert R; DeWit L; Nooijen WJ; Bruning PF
Eur J Cancer; 1992; 28A(10):1716-8. PubMed ID: 1389492
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: patterns of failure, late toxicity and second malignancies.
Vlachaki MT; Ha CS; Hagemeister FB; Fuller LM; Rodriguez MA; Besa PC; Hess MA; Brown B; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):609-16. PubMed ID: 9336140
[TBL] [Abstract][Full Text] [Related]
17. Subdiaphragmatic stage I & II Hodgkin's disease: long-term follow-up and prognostic factors.
Liao Z; Ha CS; Fuller LM; Hagemeister FB; Cabanillas F; Tucker SL; Hess MA; Cox JD
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1047-56. PubMed ID: 9719114
[TBL] [Abstract][Full Text] [Related]
18. The development of Graves' disease following radiation therapy in Hodgkin's disease.
Loeffler JS; Tarbell NJ; Garber JR; Mauch P
Int J Radiat Oncol Biol Phys; 1988 Jan; 14(1):175-8. PubMed ID: 3335451
[TBL] [Abstract][Full Text] [Related]
19. Early-stage Hodgkin's disease: long-term results with radiotherapy alone or combined radiotherapy and chemotherapy.
Brusamolino E; Lazzarino M; Orlandi E; Canevari A; Morra E; Castelli G; Alessandrino EP; Pagnucco G; Astori C; Livraghi A
Ann Oncol; 1994; 5 Suppl 2():101-6. PubMed ID: 7515642
[TBL] [Abstract][Full Text] [Related]
20. [Hypothyroid hypertrophic myopathy following mantle irradiation for Hodgkin's disease. A case].
Weber JC; Dufour P; Maloisel F; Tranchant C; Jung G; Damonte JC; Giron C; Oberling F
Rev Med Interne; 1991; 12(3):205-8. PubMed ID: 1896713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
